Vibrio vulnificus sepsis successfully treated with antibiotics, surgical debridement, and recombinant human activated protein C.
Anand
Rishi G
RG
Louisiana State University School of Medicine, New Orleans, USA.
Lopez
Fred A
FA
deBoisblanc
Ben
B
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003646:Debridement; D006801:Humans; D008297:Male; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014735:Vibrio Infections / Q000601:surgery / Q000628:therapy*; D041261:Vibrio vulnificus
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated